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Executive summary
A core question for policy-makers will be the extent to which investments 
in preventive actions that address some of the social determinants of health 
represent an effi cient option to help promote and protect population health. 
Can they reduce the level of ill health in the population? How strong is the 
evidence base on their effectiveness and, from an economic perspective, 
how do they stack up against investment in the treatment of health problems? 
Are there potential gains to be made by reducing or delaying the need for the 
consumption of future health care resources? Will they limit some of the wider 
costs of poor health to society, such as absenteeism from work, poorer levels of 
educational attainment, higher rates of violence and crime and early retirement 
from the labour force due to sickness and disability?
This policy summary provides an overview of what is known about the economic 
case for investing in a number of different areas of health promotion and 
non-communicable disease prevention. It focuses predominantly on addressing 
some of the risk factors for health: tobacco and alcohol consumption, impacts 
of dietary behaviour and patterns of physical activity, exposure to environmental 
harm, risks to mental health and well-being, as well as risks of injury on 
our roads.
It highlights that there is an evidence base from controlled trials and well-
designed observational studies on the effectiveness of a wide range of health 
promotion and disease prevention interventions that address risk factors to 
health. Moreover, the cost–effectiveness of a number of health promotion and 
disease prevention interventions has been shown in multiple studies. Some of 
these interventions will be cost-saving, but most will generate additional health 
(and other) benefi ts for additional costs. 
In many cases combinations of actions, for example in the areas of tobacco, 
alcohol and road injury prevention, are often more cost-effective than 
relying on one action alone. In terms of individual actions the use of taxes to 
infl uence individual choices on the use of tobacco and alcohol, as well as the 
consumption of food, is consistently seen as a cost-effective intervention to 
promote better lifestyle choices. Media-based campaigns, in contrast, are not 
always effective or cost-effective. Interventions targeted at children often have 
the most potential to be cost-effective because of the longer time-frame over 
which health benefi ts can be realized. 
While some interventions may take several decades to be seen to be cost-
effective, for example impacts on the risk of obesity, there are some health 
promotion and disease prevention actions that are cost-effective in the 
short term, for instance related to the protection of mental health in the 
workplace. There are opportunities to invest in cost-effective health promoting 
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interventions that can be delivered universally as well as to target population 
groups, for instance in schools or workplaces.
However, this evidence base must be treated with caution, given that many 
interventions have only been assessed in a small number of settings, and 
different economic methods and assumptions are made in different studies. 
Most of the economic evidence identifi ed has been undertaken in high-
income countries, with very few studies applied to other settings in the 
WHO European Region. 
Moreover, much of the evidence on the long-term costs and benefi ts of 
interventions has been estimated using simulation modelling approaches 
synthesizing data on effectiveness, epidemiology and costs. This refl ects the 
lack of long-term observed effectiveness data for many public health and health 
promoting interventions. It also means that policy-makers need to be cautious 
on assumptions made about the persistence of effect of health promoting 
interventions, for example the likelihood of long-term behaviour change. 
The issue of equity is also a particularly important consideration. If the uptake 
of a public health intervention is higher in more affl uent groups in society then 
one unintended consequence of investment in a public health programme 
could be to inadvertently widen health inequalities. We have little data from 
our review on the impact of interventions on health inequalities. Finally there 
are also challenges to be met to in order to help encourage the implementation 
of cost-effective health promotion and disease prevention actions. 
Notwithstanding these caveats, it is clear that there is an economics evidence 
base for health promotion and disease prevention. The challenge now is to 
strengthen this evidence base further and look at ways in which it may be used 
to translate evidence-based knowledge into routine everyday practice across all 
of the WHO European Region. For instance, given that these actions are often 
delivered outside of the health system it is helpful to speak the same language 
and highlight the economic benefi ts of most interest to the sectors that are 
responsible for funding each action.
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Key messages
There is an evidence base from controlled trials and well-designed observational 
studies on the effectiveness of a wide range of health promotion and disease 
prevention interventions that address risk factors to health. These include 
measures to reduce the risk of smoking and alcohol consumption, increase 
physical activity and promote more healthy diets, protect psychological 
and emotional well-being, reduce environmental harms and make road 
environments safer.
Many of these actions may be both funded and delivered outside of the 
health sector.
There is also an evidence base suggesting that a number of cost-effective 
health promotion and disease prevention interventions are available. Some of 
these interventions will be cost-saving, but most will generate additional health 
(and other) benefi ts for additional costs. However this evidence base must be 
treated with caution, given that many interventions have only been assessed 
in a small number of settings and different methods and assumptions are made 
in different studies.
Combinations of actions, for example in the areas of tobacco, alcohol and 
road injury prevention, are often more cost-effective than relying on one 
action alone.
The use of taxes to infl uence individual choices on the use of tobacco and 
alcohol, as well as the consumption of food, is consistently seen as a cost 
effective intervention to promote better lifestyle choices.
Much of the evidence on the long-term costs and benefi ts of interventions 
has been estimated using simulation modelling approaches synthesizing 
data on effectiveness, epidemiology and costs. This refl ects the lack of 
long-term observed effectiveness data for many public health and health 
promoting interventions. It also means that policy-makers need to be cautious 
on assumptions made about the persistence of effect of health promoting 
interventions, e.g. the likelihood of long-term behaviour change.
Interventions targeted at children often have the most potential to be cost-
effective because of the longer time-frame over which health benefi ts can 
be realized.
While some interventions may take several decades to be seen to be cost-
effective, for example impacts on the risk of obesity, there are some health 
promotion and disease prevention actions that are cost effective in the 
short term. 
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There are opportunities to invest in cost-effective health promoting 
interventions that can be delivered universally as well as to target population 
groups, for instance in schools or workplaces.
Most of the economic evidence identifi ed is from research undertaken in 
high-income countries, with very few studies applied to other settings in 
the WHO European Region. 
In order to help encourage the implementation of cost-effective health 
promotion and disease prevention actions it is helpful to highlight economic 
benefi ts of most interest to the sectors that are responsible for funding 
these actions.
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 1 Introduction
European health systems face considerable challenges in promoting and 
protecting health at a time when the pressure on budgets and resources in 
considerable in many countries. New estimates of the global burden of disease 
for non-communicable diseases, including heart disease and stroke, diabetes, 
cancer, chronic lung diseases, low back pain and poor mental health, indicate 
that in western, central and eastern Europe they account for 85%, 80% and 
75% respectively of the global burden of disease. Similarly injuries, particularly 
on the roads or as a result of self-harm, account for a further 10%, 11% or 
18% of total disease burden (Institute of Health Metrics, 2013).
The importance of these challenges is recognized in the new health policy 
framework and strategy of the WHO European Region, Health 2020 (WHO, 
2013). This is focused on improving the health and well-being of populations, 
reducing health inequalities, strengthening public health and ensuring the 
sustainability of health systems. Importantly, it takes a whole-of-government 
and whole-of-society perspective, emphasizing the importance of actions which 
go well beyond the traditional boundaries of the health sector and ministries 
of health.
A core question for policy-makers will be the extent to which investments 
in health promotion and preventive actions addressing some of the social 
determinants of health can pay off. Can they reduce the level of ill health in 
the population? How strong is the evidence base on their effectiveness and, 
from an economic perspective, how do they stack up against investment in 
the treatment of health problems? For example, are there potential gains to 
be made by reducing or delaying the need for the consumption of future 
health care resources? Will investments in health promotion and preventive 
actions limit some of the wider costs of poor health to society, such as 
absenteeism from work, poorer levels of educational attainment, higher 
rates of violence and crime and early retirement from the labour force due 
to sickness and disability?
Growth in the evidence base
The last 20 years have certainly seen a dramatic growth in both the volume 
and quality of evidence on the effectiveness and cost–effectiveness of 
health care interventions. Many countries formally make use of such evidence 
when considering whether to reimburse new health care interventions and 
procedures. Less attention has focused on the strength of the evidence for 
some health promotion and disease prevention strategies, despite their integral 
contribution to health policy. Poor health behaviours can have many adverse 
external impacts, for instance the risk of violence to other family members 
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because of alcohol abuse or the dangers of passive smoking in workplaces. 
Some of these poor behaviours may be due to addiction, a lack of information 
on risk or a misplaced belief that these negative consequences of poor health 
can defi nitely be avoided. They may also refl ect social injustice, emphasizing 
the importance of addressing socioeconomic and cultural factors that can lead 
to inequalities in health status. 
This policy summary provides an overview of what is known about the 
economic case for investing in a number of different areas of health 
promotion and non-communicable disease prevention focused predominantly 
on addressing some of the risk factors for health: tobacco and alcohol 
consumption, impacts of dietary behaviour and patterns of physical activity, 
exposure to environmental harm, risks to mental health and well-being, as 
well as risks of injury on our roads. The subsequent sections of this summary 
summarize some of the fi ndings from a new synthesis on the state of the art 
in the economics of health promotion and disease prevention (McDaid, Sassi 
& Merkur, forthcoming). All costs are reported in 2012 international dollars.
In addition, the summary seeks to place this evidence in context, including 
considering the consequences of inequalities in health. It considers some of the 
challenges in translating this evidence base into implemented actions that often 
may be funded and delivered by non-health sector budget holders. 
2 Tobacco smoking
Smoking brings enormous physical harm to its users. There is a huge body 
of knowledge documenting its manifold risks, its high public costs and the 
effective means to control its use. It is the cause of 1 250 000 Europeans’ 
deaths each year, causing 21% of all deaths, including 330 000 in the Russian 
Federation and around 100 000 in each of the United Kingdom, Germany, 
Ukraine and Italy. The WHO European Region’s smoking rates are among 
the highest in the world with 40% of men smoking, 18% of women and 
24% of young people aged 15 years (WHO, 2011d). 
Evidence-based tobacco control policies are shown to be highly cost-effective 
and many are cost-saving (Table 1) (Townsend, forthcoming). Price is a major 
factor determining use and the prices of the “cheapest cigarettes” vary 
twentyfold between countries, while prices of the “most sold cigarettes” 
vary ninefold. Each 10% difference in price is associated with a 2.5–5% 
difference in cigarette consumption in the opposite direction, and price 
differences account for much of the threefold difference in smoking rates 
between European countries, which are highest in countries where prices 
are lowest, among lower socioeconomic groups, the unemployed and lone 
parents. They are a major cause of inequalities in health and mortality.
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Raising cigarette prices across Europe even to the average European Union (EU) 
price of $5.50 would save hundreds of thousands of lives per year including 
100 000 in the Russian Federation (Townsend, forthcoming). Public health 
advocates continue to appeal for higher tobacco taxes on the basis of social 
costs, and few individuals would deny the justifi cation of a tax increase based 
on the health benefi ts.
The most cost-effective tobacco control policy is raising taxes. A 10% price 
increase could result in 0.6 to 1.8 million fewer premature deaths in eastern 
European and central Asian countries, at a cost of only $5 to $125 per 
disability-adjusted life-year (DALY) in the short run (Ranson et al., 2002; 
Lai et al., 2007; Chisholm et al., 2006; Ortegon et al., 2012; Vos et al., 2010). 
Several studies have estimated that the reduction in demand would be twice 
as much in the long run as in the short run, given a continuous increase in real 
price to keep pace with infl ation. Research from many countries reports on 
increases in government tax revenue following from tobacco tax rate increases, 
and also falls following reductions in the real tax rate.
A comparative cost-effective modelling study estimated the incremental cost 
per quality-adjusted life-year (QALY) of various cessation interventions over 
and above the non-intervention control rate of quitting. Brief opportunistic 
advice from a general practitioner (GP) with telephone or self-help material (A) 
was the most cost-effective, next was opportunistic advice alone from a GP 
or hospital nurse (B), and lastly opportunistic advice plus nicotine replacement 
therapy (NRT) (C) was still cost-effective but at four times the cost of B and 
eight times the cost of A (Parrott, Godfrey & Kind, 2006). The more effective 
methods, being expensive, are not the more cost-effective and there is debate 
as to whether NRT works at a population level. Other modelling studies also 
point to the cost–effectiveness of smoking cessation measures (Vos et al., 2010; 
Ranson et al., 2002; Chisholm et al., 2006).
A particularly important area for cessation relates to pregnant women. A 
United Kingdom study estimated that spending $24–$64 per pregnant smoker 
on low-cost smoking cessation interventions would be cost-saving (Public 
Health Research Consortium, 2010). Evidence from a number of studies in 
high-, middle- and low-income countries indicates that these are cost-effective 
(Hurley & Matthews, 2008; Ratcliffe, Cairns & Platt, 1997; Secker-Walker et al., 
1997; Ha & Chisholm, 2011; Chisholm et al., 2006).
Population-based approaches to smoking cessation using mass media 
campaigns are important because they raise awareness and change attitudes 
about the risks of using tobacco and the benefi ts of quitting; however, 
these tend to be neglected so important tobacco control opportunities have 
been missed (Lawrence, Mitrou & Zubrick, 2011; Flay, 1987; WHO, 2003). 
Widespread media reporting of research fi ndings showing the harmful 
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effects of tobacco have been particularly effective where knowledge of the 
health consequences of tobacco use is low, as is often the case in emerging 
economies (Jha & Chaloupka, 1999).
Advertising bans were the earliest responses to the need for tobacco control. 
The effects are not easy to measure due to the time required to achieve the full 
effect, which may then last for many years. The tobacco advertising ban was 
estimated to have reduced consumption in New Zealand by 5.5% (Department 
of Health, 1989), in Canada by 4%, (Department of Health, 1992), in Finland 
by 7% (Pekurinen, 1989), and in Norway by 16% (Laugesen & Meads, 1991). 
An OECD study of 22 countries reported a signifi cant effect of different levels 
of advertising restriction, scored from 1 to 10, with each point associated with 
a 1.5% decrease in consumption (Laugesen & Meads, 1991). On average, it is 
estimated that advertising bans reduce smoking by some 7%, but partial bans 
have little or no effect on smoking as the tobacco industry simply re-channels 
its marketing to other media (Saffer & Chaloupka, 1999).
Other actions to improve consumer information, including labelling, smoking 
restrictions in public places and advertising bans, often generate savings in 
health care expenditures which offset any implementation costs. Even when 
this is not the case, the cost–effectiveness of these interventions is among 
the best in the entire health sector (less than $1115 per DALY saved or QALY 
gained), with the potential to avoid a major proportion of the health and 
economic burden of smoking (Chisholm et al., 2006).
Warning labels on cigarette packs are recommended by the Framework 
Convention on Tobacco Control, are a requirement for EU countries, and are 
among the most direct and prominent means of communicating with smokers 
(Hammond, 2011). To increase the potential for effectiveness, warning labels 
should be prominent, placed on the largest surfaces of the packages, and be 
very distinct graphically from the rest of the package design (Strahan et al., 
2002). Australia requires by law plain packaging of cigarettes, and India, New 
Zealand and the United Kingdom have all considered bills for plain packaging.
Preventing smoking in public places has been shown to reduce smoking 
prevalence and increase cessation. In a recent review of 37 studies of smoke-
free policies in worksites or communities (1976–2005), 21 reported reduced 
prevalence of 3.4% and a further 11 studies reported increased cessation 
of 6.4%; 4 of the studies demonstrated economic benefi ts (Hopkins et al., 
2010). A time series analysis of 21 countries or states which had implemented 
comprehensive smoke-free legislation reported that the legislation had 
increased the rate at which prevalence was declining in some locations, but in 
the majority had no measurable impact on existing trends (Bajoga et al., 2011). 
Some countries have reported reductions in heart disease deaths following 
smoke-free legislation and it is generally considered to be highly successful. 
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Such interventions have also been shown to be cost-effective (Chisholm et al., 
2006). The most effective means of reducing youth smoking is to reduce adult 
smoking, via the mechanism of price increases, smoke-free policies, and of 
good, well-directed multimedia programmes.
A number of economic studies indicate that combining many of these 
interventions leads to greater health benefi ts while still being cost-effective 
(Chisholm et al., 2006; Lai et al., 2007; Ortegon et al., 2012). Adequate 
implementation and monitoring, government policies formulated without 
infl uence from the tobacco industry, and action against corruption are needed 
to support policies.
3 Physical inactivity
Physical activity is a leading factor in good health. However, more than one 
in three people living in the WHO European Region are not active enough 
(WHO, 2011a). This makes physical inactivity a leading risk factor both in terms 
of mortality and morbidity, imposing a fi nancial burden that ranges between 
$150 and $300 per individual per year (Cavill, Kahlmeier & Racioppi, 2006). 
There is a strong economic case for investing in efforts to tackle physical 
inactivity (Cecchini & Bull, forthcoming), as shown in Table 2. Policies and 
programmes towards this end are varied, generally aimed at reducing the risk 
of chronic conditions and with a strong focus on counteracting obesity. In this 
section, we take stock of policies already in place and examine the available 
evidence on the effectiveness and cost–effectiveness of the most promising 
prevention interventions.
Mass media campaigns have been shown to have a positive, moderate effect 
on the increase of physical activity in targeted populations (Leavy et al., 2011; 
Cavill & Bauman, 2004; Kahn et al., 2002). Moreover, when used to increase 
physical activity, mass media campaigns are among the best buys to tackle 
non-communicable diseases with a good cost–effectiveness ratio and could 
even be cost-saving in a few cases (WHO, 2011c; Lewis et al., 2010; Sassi et al., 
2009; Cobiac et al., 2009; Vos et al., 2010; Cecchini et al., 2010). 
School-based interventions aim at increasing the amount of physical activity of 
children attending school, mainly by providing additional information on the 
benefi ts of increased physical fi tness and by providing increased opportunities 
and time to undertake physical activity. A growing literature is focused on 
encouraging walking and cycling to school (Lee, Orenstein & Richardson, 2008; 
NICE, 2008c), though cycling interventions do not appear to be as effective 
as walking interventions in increasing students’ physical activity levels. School-
based interventions exclusively aimed at increasing physical activity have a lower 
cost–effectiveness ratio compared to mass media campaigns and primary-care 
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interventions (WHO, 2011c). However, some school-based interventions may 
be cost-effective (Lewis et al., 2010; Sassi et al., 2009; Wang et al., 2003); in 
particular, interventions that combine actions on physical activity and diet seem 
to be more effi cient than interventions on a single domain.
Primary-care interventions show positive and moderate effectiveness on 
reported levels of physical activity (Breckon, Johnston & Hutchison, 2008; 
Fleming & Godwin, 2008; Williams et al., 2007). In some cases, this is 
correlated to an improvement of physiological parameters, such as blood 
pressure or lipid profi le. Compared to other approaches, primary-care 
interventions have a good cost–effectiveness ratio, despite the higher costs 
of some approaches (Garrett et al., 2011; Lewis et al., 2010; Sassi et al., 2009; 
WHO, 2011c) . In an assessment of four interventions, two of which were in 
primary care (exercise referral and brief interventions), the National Institute of 
Health and Care Excellence (NICE) concluded that only the “brief intervention” 
approach should be recommended (NICE, 2008c). 
Typical worksite programmes employ a range of strategies rather than a single 
action, and are usually offered to all employees. Examples of approaches 
include supporting active travel (e.g. walking and cycling to/from work) 
through provision of adequate facilities (e.g. bike storage, showers), incentives 
and discounts for fi tness clubs, health education programmes and individual 
employee health checks (Bull, Adams & Hooper, 2008). But, compared to 
other approaches, worksite interventions offer smaller population coverage 
(Sassi et al., 2009; Cecchini et al., 2010). Recent reviews have reported positive 
effects on physical activity behaviour, fi tness, anthropometric measures and 
lipids (Proper et al., 2003; Abraham & Graham-Rowe, 2009; Conn et al., 
2009; Dugdill et al., 2008). On job-related outcomes, such as reduction of 
absenteeism and stress, the effect sizes were positive but not always signifi cant. 
WHO grades worksite interventions as being quite cost-effective (i.e. less 
than three times gross domestic product [GDP]/capita per DALY prevented), 
mainly because of higher implementation costs (WHO, 2011c). A better 
cost–effectiveness ratio may be achieved once other factors (e.g. decreased 
absenteeism) are taken into consideration (NICE, 2008b; Bending, Beale & 
Hutton, 2008; Lewis et al., 2010).
The promotion of walking through travel/transport-related interventions may 
be effective in achieving a positive increase in walking trips (Ogilvie et al., 
2007). The evidence on efforts to encourage cycling, which often includes 
health education combined with modifi cations to infrastructure and/or travel 
conditions (e.g. bike lanes, off-street paths and traffi c-calming actions) is 
equivocal. There is good evidence, however, that a comprehensive set of 
infrastructures can lead to increases in cycling; for instance, a 3% increase 
in the proportion of bicycle trips was found in a Dutch example when cycle 
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route networks were extended. Several cost–benefi t analyses in high-income 
countries suggest positive returns from investment in cycle trails (Sassi et al., 
2009). An economic assessment (Beale, Bending & Trueman, 2007) carried out 
for the National Institute for Health and Clinical Excellence (NICE) guidelines on 
creating an environment that supports physical activity (NICE, 2008a) suggests 
that travel/transport-related interventions could be cost-effective under a 
number of assumptions. Two health economic assessment tools (HEAT) that 
assist in the assessment are HEAT walking and HEAT cycling. Application of 
these tools and further research is needed to develop the knowledge base in 
this fi eld (WHO, 2011b).
Community-based interventions encompass a diverse range of interventions 
accessible to the whole community. Pedometer-based programmes have 
become popular in recent years due to the low cost of the devices and 
the advantage of an objective measure of activity levels, and have been 
shown to be effective in children and adults in the short term (Lubans, 
Morgan & Tudor-Locke, 2009; Bravata et al., 2007). Providing step-based 
goals (e.g. 10 000 steps per day) rather than time-based goals (e.g. walk 
for 30 minutes) has been shown to be more effective, and effectiveness is 
increased when efforts are combined with behaviour change support and 
goal setting (Williams et al., 2008a; Ogilvie et al., 2007). Pedometers have 
been modelled to be cost-effective in an Australian context (Vos et al., 
2010). Also, walking groups and remote mediated interventions, such as 
telephone or web-based support and print materials, have also been found 
to be potentially effective. Though no comprehensive assessment of the cost–
effectiveness of community-based interventions has been carried out (WHO, 
2011c), community-based interventions would have a cost–effectiveness ratio 
that ranges from a few thousand dollars to about $70 000 per DALY/QALY 
(Sassi et al., 2009). For children specifi cally, there is only mixed evidence on 
the cost–effectiveness of walking buses (NICE, 2009a; Moodie et al., 2009; 
Fordham, 2008). 
It is diffi cult to change people’s attitudes and behaviours but collected 
evidence clearly demonstrates that tackling physical inactivity is an affordable 
and effi cient means of increasing the health of a population. A number of 
challenges may hinder the success of translating what we know works into 
suitable policies and actions. Consistent monitoring systems, closer cooperation 
between all the relevant actors, as well as inclusion of multiple, coherent, 
long-lasting and large-scale strategies are identifi ed as key factors in creating 
national policies. 
 Policy summary
8
4 Unhealthy diets
Unhealthy diets, particularly those involving an excessive consumption of 
salt, sugar and fat, energy-dense, nutrient-poor foods and limited intake 
of fruit and vegetables and whole-grains contribute to a range of chronic, 
non-communicable diseases. These diseases are increasingly prevalent in the 
European region, and impose a substantial burden on health, the economy 
and society as a whole. Moreover, there has been a greater than three-fold 
rise in overweight/obesity prevalence since the 1980s in the WHO European 
Region, even in countries with traditionally low rates (Branca, Nikogosian 
& Lobstein, 2007). 
Obesity alone is estimated to account for approximately 1% to 3% of total 
health expenditure in most countries (Tsai, Williamson & Glick, 2011). An 
obese person incurs health care expenditures at least 25% higher than those 
of a normal weight person (Withrow & Alter, 2011). Combined, the leading 
behavioural and metabolic risk factors associated with nutrition (high blood 
pressure, high blood glucose, overweight and obesity, high cholesterol, 
low fruit and vegetable intake) plus physical inactivity are estimated to be 
responsible for almost 80 DALYs per 1000 population over age 30 in the WHO 
European Region, which is more than any other world region (WHO, 2009). 
Table 3 highlights the economic case for population-based policies to change 
food environments, targeting information and aspects of the marketplace, as 
a means of preventing and controlling diet-related chronic non-communicable 
diseases (Hawkes & Sassi, forthcoming). Some policies may be best targeted 
at whole food groups, with others taking a nutrient-based approach. The 
effectiveness of policies may vary across population groups, and different policy 
actions can be combined.
Starting with the food information environment, the evidence from economic 
studies of information campaigns is rather mixed. Some studies conclude that 
information campaigns can be cost-effective but this is based on the low cost 
of these actions, with actual effectiveness being limited largely to impacts on 
knowledge and specifi c populations. For example, the effects of a mass media 
campaign aimed at increasing fruit and vegetable intake, as well as physical 
activity, were assessed in a multi-country study based on a microsimulation 
approach (Sassi, 2010; Sassi et al., 2009). The study found that the campaign 
would have a favourable cost–effectiveness ratio starting from about ten years 
from its initial implementation, but its health effects would be smaller than 
those of any of the other strategies examined. Worksite information campaigns 
often accompanied by changes in catering are not effective (Cobiac, Vos & 
Veerman, 2010b; Engbers et al., 2006). In developing country settings, model-
based studies found that mass media campaigns for salt, saturated fat and 
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cholesterol reduction had a more favourable cost-effectiveness profi le 
(Ha & Chisholm, 2011; Willett et al., 2006).
Nutrient lists and labels on food packages and menus as well as rules on 
nutrient and health claims fall under the category of labelling. In Europe, 
nutrient labelling will become mandatory in December 2016 (European 
Commission, 2011). The existing studies show there is convincing evidence 
that consumers use nutrient lists, but lower socioeconomic status (SES) groups 
lag behind in label use. Food labelling schemes were found to perform better 
than information campaigns in terms of cost–effectiveness, especially when 
implemented on a mandatory basis, but the studies available to support this 
claim are few and vary in the types of schemes assessed and methods applied. 
One multi-country modelling study found that mandatory labelling would have 
a favourable cost–effectiveness ratio in the EUR-A sub-section of the WHO 
European Region, as well in a number of non-European countries at different 
levels of income (Sassi et al., 2009). Although cost-effective, nutrient lists 
were estimated to have smaller health effects than fi scal measures. Evidence 
from Australia on interpretative labels is consistent with these fi ndings. Traffi c 
light labelling was shown to be cost-effective (Sacks et al., 2011) and using a 
mandatory “tick” symbol to indicate products low in salt, with the expected 
effect of food companies signifi cantly reducing salt content, was shown to be 
effective and cost-saving (Cobiac, Vos & Veerman, 2010a). 
Restrictions in the commercial promotion of food, was shown to be cost-
effective in a small number of model-based economic studies focusing on 
restricting food advertising to children. One of these studies compared the 
cost–effectiveness of restricting commercial promotion through mandatory 
and self-regulatory approaches in fi ve countries (Sassi, 2010; Sassi et al., 2009; 
Cecchini et al., 2010). Restrictions were highly cost-effective in the 20 years 
after implementation, especially in low- and middle-income countries, where 
they may even be cost-saving in some instances. Self-regulation (assuming half 
the effectiveness, compared with statutory regulation, at the individual level) 
had signifi cantly lower costs but also limited effectiveness. Also, the extension 
of existing regulations in Australia to include food advertising during specifi ed 
children’s TV viewing hours was highly cost-effective (Magnus et al., 2009).
The economic evidence available on policies aimed at affecting the marketing 
environment for food choices appears more solid and broadly based. Policies 
aimed at making fruit and vegetables more available in schools were found 
to have positive, albeit modest, effects on dietary intake. Evidence from the 
Netherlands found these initiatives to be cost-effective, although the fi nding 
was sensitive to assumptions regarding the sustainability of dietary changes 
in the long term (te Velde et al., 2011). When comparing two school-based 
interventions, the dominant intervention entailed multiple components, 
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including provision of free fruit and vegetables twice weekly, delivery of 
health education as part of the school curriculum, with feedback and parental 
involvement, and assumed 30% of the effect to be permanent. In the less 
effective intervention, the latter components were absent and schools were 
encouraged, but not mandated, to provide health education. 
Policies aimed at altering the prices of less healthy foods through the use 
of taxes were more thoroughly investigated by means of economic models. 
Existing studies show that taxes on foods high in salt, sugar and fat, and on 
“junk food” are consistently cost-saving, that is, they cost less to implement 
than they save in terms of reduced health care expenditures, and they have a 
favourable health impact at the population level (Smith-Spangler et al., 2010; 
Sacks et al., 2011). Food taxes are likely to be regressive, although the less well 
off also benefi t disproportionately from their effects, and need to be designed 
carefully in order to avoid undesirable substitution effects in food consumption, 
and minimise administrative and compliance costs. Both the effectiveness and 
the distributional impact of taxes may be improved by coupling them with 
subsidies targeting healthy foods or disadvantaged consumers (Sassi, 2010; 
Sassi et al., 2009; Cecchini et al., 2010). In contrast, studies in France and 
Australia suggest that the use of discounts, reductions in VAT, or provision of 
food stamps for fruit and vegetables are not cost-effective (Dallongeville et al., 
2011; Cobiac, Vos & Veerman, 2010b).
Product reformulation policies aimed at reducing the salt content of processed 
foods were found to be cost-saving or to have a favourable cost–effectiveness 
ratio in several economic evaluations (Wang & Labarthe, 2011; Barton et al., 
2011; Eatwell, 2012). Reductions in salt from both voluntary and legislative 
measures were found to be cost-effective, but legislation more so (Murray 
et al., 2003). In Norway, the effect of industry reformulation combined with 
an information campaign was modelled; these actions would be cost-saving 
(Selmer et al., 2000). For the United Kingdom, the estimate was made (using 
actual data) for both voluntary salt reduction by industry and an information 
campaign. On the basis that the salt reduction initiative saved 44 000 QALYs, 
it was found to be cost-effective and when savings to the National Health 
Service are included ($116 million), it was found to be dominant (Eatwell, 
2012). In Argentina, reducing salt in bread was found to be cost-saving, and 
more cost-effective than any of the other interventions analysed (Rubinstein 
et al., 2010). A study focused on developing countries found a legislated 
reduction in salt content of manufactured foods and an accompanying 
public education campaign would be cost-effective (Willett et al., 2006). 
The economic evidence on other instances of reformulation (e.g. to reduce 
transfat content) is very limited.
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No cost–effectiveness studies were found to include interventions to change the 
“architecture” of food choices, and which impose restrictions on the availability 
of snacks and drinks in schools (Gittelsohn, Rowan & Gadhoke, 2012; Chriqui, 
2012; Jaime & Lock, 2009). Many also lack substantial effectiveness evidence. 
Particularly critical gaps in the effectiveness evidence are those regarding 
agricultural and food-chain incentives, and more generally the effects of supply-
side changes triggered by government policies, such as regulation of labelling 
and health claims. A further important gap is that concerning the broader 
effects of interventions on people’s and populations’ overall dietary behaviours. 
Even where evidence is available, this is often unsatisfactory owing to its limited 
generalizability, its reliance on relatively weak investigation approaches and/or 
its use of outcome measures only loosely linked with changes in dietary 
behaviours and health. 
Thus, the evidence reviewed here provides initial support for a set of policy 
actions aimed at improving the quality of people’s diets, and a useful starting 
point for setting a detailed research agenda, which will enable policy-makers 
to consider a broader range of actions in the future, with a better knowledge 
than we have at present of the full range of consequences those actions 
may produce.
5 Alcohol
Economic effi ciency can be improved in the alcohol market when market 
failures are addressed, negative externalities due to alcohol are reduced 
and a socially optimum level of alcohol is consumed. Market failures 
include the involvement of children and adolescents as consumers, a built-
in neurobiological reaction of the brain which overestimates advantages 
of consuming alcohol, irrespective of harm, and a failure of price to refl ect 
alcohol’s negative impact on health (Anderson & Baumberg, 2006). 
Negative externalities include the health and social costs of alcohol. Alcohol, 
and more so sustained heavy drinking, impairs personal security, health, 
educational attainment and productive employment. For example, among 
those aged 15–64 years living in the EU in 2004, 138 000 died of an alcohol-
related cause, of which 7700 (5.6%) were deaths in people other than the 
drinker (Rehm et al., 2012). Alcohol costs societies some 2–3% of GDP, mostly 
from lost productivity (Rehm et al., 2009a), a fi gure likely to double if the costs 
to people other than the drinker are included (Laslett et al., 2010). At any given 
level of alcohol consumption, poorer people can be as much as three or four 
times as likely to die from an alcohol-related condition as richer people (Rehm 
et al., 2009b).
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An optimum level of societal consumption can be one where the level of harm 
is minimized. Taking into account that alcohol can reduce the risk of ischaemic 
diseases, including heart disease, it has been estimated that the optimum level 
of consumption in the United Kingdom for the adult population as a whole is 
3 g of alcohol per day, about 50 ml of 5% beer (Nichols et al., 2012).
Collated evidence on the cost–effectiveness of alcohol policies is shown in 
Table 4 (Anderson, forthcoming). The three most cost-effective alcohol policies 
for reducing alcohol-related harm, and ones which correct alcohol’s market 
failures, are price increases, restrictions on availability and bans on advertising 
(World Economic Forum & WHO, 2011). As Table 4 indicates, not all interventions 
are cost-effective: there is insuffi cient evidence on the effectiveness of school-
based and mass media campaigns (Anderson, Chisholm & Fuhr, 2009). 
Price increases represent the most cost-effective response throughout the 
world in reducing the harm done by alcohol, including heavy drinking, 
alcohol-related deaths, costs to health and criminal justice systems, and lost 
productivity (Österberg, 2012b; Lai et al., 2007; Anderson, Chisholm & Fuhr, 
2009; Chisholm et al., 2004, 2006). Increasing prices through alcohol tax 
increases can be mitigated by illegal production, tax evasion and illegal trading 
in some jurisdictions. Reducing this unrecorded consumption via concerted tax 
enforcement strategies by law enforcement and excise offi cers is estimated to 
cost more than a tax increase but produces similar levels of effect (Anderson, 
Chisholm & Fuhr, 2009). 
To be effective, tax increases need to accommodate changes in the affordability 
of alcohol compared with other goods (Rabinovich et al., 2009); targeted taxes 
on specifi c types of alcohol do not necessarily work (Anderson, Suhrcke & 
Brookes, 2012); tax regimes can be used in differing jurisdictions to support the 
maintenance of non-drinking behaviour or to favour products containing lower 
alcohol levels.
Setting a minimum price per gram of alcohol sold is one form of price policy 
that is particularly effective in reducing alcohol-related harm, and one that 
prevents markets being fl ooded with particularly cheap alcohol that fuels 
heavy drinking occasions and heavy drinkers (Purshouse et al., 2010; Stockwell 
et al., 2012). 
Restricting availability of alcohol increases the time costs and inconvenience in 
obtaining alcohol and leads to reduced harm (Österberg, 2012a). It is also cost-
effective (Anderson, 2009; Anderson, Chisholm & Fuhr, 2009; Chisholm et al., 
2004, 2006). Increasing the time alcohol is on sale by as little as two hours, 
and increasing the number of places where alcohol can be bought in any given 
location are linked to increases in alcohol consumption and harms, including 
injury, violence, crime and medical harm. In contrast, reducing the number of 
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hours alcohol is on sale reduces violence and damage, assaults and murders. In 
many countries governments own retail outlets. These government monopolies, 
which limit outlet density and the hours and days alcohol is on sale, as well as 
removing the private profi t motive for increasing sales, result in reduced alcohol 
consumption and alcohol-related harm (Österberg, 2012a).
Banning the advertising of alcohol, as is the case for tobacco, is estimated to 
be a very cost-effective measure if fully enforced (Anderson, 2009; Anderson, 
Chisholm & Fuhr, 2009; Chisholm et al., 2004, 2006). Econometric studies 
fi nd positive relationships between expenditure on alcohol advertising and 
alcohol consumption (Anderson, 2009). A wealth of evidence from longitudinal 
observational studies shows that commercial communications, particularly 
through social media and electronic communication outlets, encourages 
young non-drinkers to start drinking and existing young drinkers to drink 
more (De Bruijn, 2012). Even simply watching a one-hour movie with a greater 
number of drinking scenes or viewing simple advertisements can double the 
amount drunk during the hour-long viewing period (Engels et al., 2009). In 
many jurisdictions, much store is put on self-regulation of the content and 
volume of commercial communications, and withdrawal of communications 
that are found to breach self-regulatory codes. However, these approaches 
are found not to work, with codes poorly interpreted and extensively violated 
(Anderson et al., 2013). Further, evidence shows that withdrawn commercial 
communications simply live on, accessible to all, in social media, which are, 
in any case, heavily fi nanced by global alcohol producers (Anderson, Suhrcke 
& Brookes, 2012). Partial bans of advertising also do not work, with advertising 
companies simply fi nding creative ways to get around them (Nelson, 2010). 
Brief interventions within the health system have also been shown to be cost-
effective, but they are much less cost-effective than population-wide strategies 
(Anderson, 2009; Anderson, Chisholm & Fuhr, 2009; Chisholm et al., 2004, 
2006; Vos et al., 2010). Good enforcement of drink-driving legislation and 
countermeasures such as random breath-testing campaigns have also been 
shown in a number of modelling studies in different country settings to be cost-
effective (Anderson, 2009; Anderson, Chisholm & Fuhr, 2009; Chisholm et al., 
2004, 2006, 2012; Vos et al., 2010).
A public health alcohol strategy that combines a number of effective 
interventions generates additional health benefi ts while still remaining cost-
effective (Anderson, 2009; Anderson, Chisholm & Fuhr, 2009; Chisholm et al., 
2004, 2006). Impediments to implementing effective policy include failure to 
regulate the alcohol industry and engage it in reducing harm in any meaningful 
way. The alcohol industry could remove alcohol from the market by producing 
and selling products with a lower alcohol concentration, incentivized by 
government taxes (Anderson et al., 2013). 
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6 Environmental hazards to children’s health
Children are uniquely vulnerable to many common exposures in the environment 
(Trasande & Thurston, 2005; Thurlbeck, 1982). While environmental hazards can 
be broadly defi ned, exposure to mercury, lead, air pollutants and many synthetic 
chemicals can be modifi ed through changes in anthropogenic activities.
The health burden of mercury emissions from coal burning, which remains a 
dominant source of electricity, has been estimated to be substantial. Children 
may suffer decrements in IQ ranging from 0.2 to 5.1 points, with a resultant 
$11.3 billion loss in economic productivity of the United States (Trasande, 
Landrigan & Schechter, 2005). Abating emissions at coal-fuelled power plants 
by burning less/cleaner coal or by capturing mercury during combustion 
(with activated carbon injection fi lters) can reduce mercury hazards. The large 
uncertainty in the economic costs of mercury abatement refl ects a short history 
and lack of experience with direct regulation. In general, establishing a tax/
tradable permit system for mercury emissions from power plants would provide 
an economic mechanism by which to drive down the costs of abatement. 
A number of actions that generate a positive return on investment can be seen 
in Table 5 (Trasande & Brown, forthcoming). The United States Environmental 
Protection Agency’s (EPA) Mercury and Air Toxics Standards (which enter 
into force in 2016) set the fi rst-ever limits on mercury emissions from 
electricity generation. The initial annualized compliance costs are estimated 
at $10.4 billion in 2015, whereas the predicted health benefi ts are forecast 
to exceed $40 billion per year, including benefi ts from reduced fi ne particulate 
matter pollution (EPA, 2011). Internationally, the United Nations Environment 
Programme (UNEP) coordinates negotiations towards a legally binding global 
mercury treaty due to be completed in 2013, which would include standards 
for abatement from coal combustion (UNEP, 2011). 
Lead is similar to methylmercury in that it can impair neurological and cognitive 
function. Removing lead from petrol signifi es one of the landmark successes in 
children’s environmental health (Grosse et al., 2002; Nichols, 1997); however, 
currently lead paint in homes is the major source of childhood lead exposure 
globally, including in high-income countries. In the European region, estimates 
from various sources show that 17% of children under 15 in low- and middle-
income countries had blood lead levels (BLLs) above 5 µg/dL, with cognitive 
impairment documented at BLLs between 2 and 10 µg/dL (Bellinger, 2008; 
Binns, Campbell & Brown, 2007).In terms of mortality and morbidity effects, 
34 000 DALYs were lost in 2004 among low- and middle-income countries of 
the European region due to lead exposure among children under the age of 5 
(WHO, 2012).
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In France, the average costs of lead decontamination were calculated as 
$4136–10 642 per home (Pichery et al., 2011). On a per home basis, the 
estimated present value benefi ts of lead abatement in United States homes 
is around $212 000–295 000 (Gould, 2009). In France benefi ts of around 
$10 500–58 000 per decontaminated home, have been reported, while the 
total monetized benefi ts in 2008 of lead abatement in homes was estimated 
to be in excess of $26.40 billion For France, the total monetized benefi ts in 
2008 of lead abatement in homes is estimated to be in excess of $26.40 billion 
(Pichery et al., 2011). For both studies, these benefi ts are calculated as avoided 
cost of illness (COI) owing to lead exposure in children under the age of 6.
The biological basis of children’s unique vulnerability to outdoor air pollution 
(e.g. ozone and fi ne particulate matter) is well documented (National Research 
Council, 1993). The Clean Air Act has been shown to have a positive net 
return on investment over 20 years, taking account of health, productivity 
and ecological impacts (EPA, 2011). Across the European region, 8.7 million 
DALYs were lost in children under 5 due to outdoor air pollution. Furthermore, 
despite progressively stricter vehicle emissions standards and higher motor fuel 
taxes in the last several decades, ground-level ozone is expected to increase by 
35% in large cities throughout Organisation for Economic Co-operation and 
Development (OECD) countries between 2010 and 2050, assuming no new 
policies are introduced to control this pollution (OECD, 2012). 
Taxes on vehicles to reduce economic externalities associated with traffi c 
congestion, so-called congestion-charging schemes, have also been shown 
to have positive health impacts. In London, bronchiolitis hospitalizations 
decreased 9% compared with two years prior (Tonne et al., 2010), with costs 
for the scheme estimated at $228 million per year (Prud’homme & Bocarejo, 
2005). Ongoing study of the low-emission zone requirements that have been 
implemented over a broader geographic region may identify similar economic 
rewards (Woodcock et al., 2009). In Stockholm, emissions of major pollutants 
were reduced by over 10%, which translates into 27 avoided deaths per year 
(Johansson, Burman & Forsberg, 2009), with costs for the scheme estimated 
at $48.4 million per year (Eliasson, 2009). 
Many commercial chemical ingredients in pesticides, fl ame retardants and 
plastics are known to cause chronic and acute diseases in children (and adults) 
under certain exposure scenarios. Pruss-Ustun et al. estimate that the global 
burden of disease attributable to unintentional acute chemical poisoning and 
preventable through improved safety standards in 2004 was 5.2 million DALYs, 
with 19% of this total being concentrated in children (Pruss-Ustun et al., 2011). 
They conclude that over three-quarters of this burden could have been avoided 
through improved chemicals safety standards. Moreover, emerging laboratory 
and modest epidemiological evidence raise cause for concern about the role of 
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endocrine-disrupting chemicals in obesity (Trasande et al., 2009), while 
epidemiological studies have associated exposure to benzene, certain pesticides, 
biphenyls and 1,3-butadiene with increases in childhood malignancies.
The EU is best positioned to obtain childhood health benefi ts from improved 
regulation of chemicals through its implementation of “Regulation on 
Registration, Evaluation, Authorisation and Restriction of Chemicals” (REACH), 
beginning in 2007. REACH supersedes the US’s Toxic Substances Control Act 
(TSCA) in that it requires pre-market testing of chemicals and substitution with 
safer alternatives when less toxic alternatives exist. A European Commission 
extended impact assessment estimated the costs of implementing REACH to be 
between $3.7 and $6.9 billion (European Commission, 2003), with economic 
benefi ts of $35–71 billion over the next 30 years (Risk and Policy Analysts 
Ltd., 2003; Pickvance et al., 2005). The economic benefi ts stream described, 
however, is for adult disease prevention, especially for those consequences of 
adult occupational exposures that are likely to be prevented. 
As a regulation whose full impacts have yet to be seen, REACH should be 
closely monitored in order to see how effi ciently it can achieve its intended 
objectives. The evidence reviewed here suggests large future economic 
benefi ts to be gained through relatively modest investments which give 
children healthy environments.
7 Road-related injuries
While much of this policy summary concentrates on addressing non-
communicable disease, injuries remain a signifi cant contributor to the overall 
burden of death and disability in Europe. Here we focus on road injuries 
as they account for a large proportion of the burden of fatal and disabling 
unintentional injuries in European countries; there is a wide gap in injury rates 
and deaths between countries; and road injuries disproportionately affect 
vulnerable road users.
Over the last 20 years, road safety has improved tremendously, but in the WHO 
European Region 120 000 people still die each year. Road-related injuries are 
the leading cause of death in children and young adults aged 5 to 29 years, 
and a further 2.4 million people are estimated to be so seriously injured as to 
require hospital admission each year. In fact, 39% of injuries are to pedestrians, 
cyclists and motorcycle riders (Zambon, Sethi & Racioppi, 2009). The estimated 
annual costs, both direct and indirect, of these injuries in Europe have been 
conservatively estimated to be as much as 3% of GDP. Even in the best-
performing countries in Europe there is scope to improve safety.
Many of these injuries and deaths are potentially avoidable through investment 
in cost-effective road safety policies as highlighted in Table 6. Many of these 
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injuries and deaths are potentially avoidable through investment in cost-
effective road safety policies. There is good evidence indicating that a complex 
interaction of vehicular/equipment, human and environmental factors infl uence 
the likelihood of collisions, serious injuries and deaths (Anderson, McDaid & 
Park, forthcoming). Many interventions are not only cost-effective but likely 
to be cost-saving from a societal perspective. They include road environmental 
modifi cations, police/technological enforcement of traffi c regulations, investment 
in vehicle safety features and special targeted actions for high-risk drivers.
Traffi c-calming measures, which include road closures, traffi c islands, central 
refuges, additional pedestrian crossings and turning restrictions, generated 
average net fi rst year rates of return (FYRR) on investment of between 30% 
to 40% (Mackie, Ward & Walker, 1990), and the net FYRR was even greater 
for schemes for area-wide traffi c calming, introducing pedestrian facilities and 
crossings (Gorell & Tootill, 2001). 
Speed limit zones, sometimes in conjunction with physical measures to enforce 
slower speed (e.g. chicanes or speed humps) are probably cost-effective, 
especially in high-risk areas. Benefi ts will exceed costs over fi ve to ten years 
in many locations (Peters & Anderson, 2012; Steinbach et al., 2012; Grundy 
et al., 2008). Other cost-effective speed management mechanisms include 
roundabouts at hazardous junctions in Sweden (Elvik et al., 2009; European 
Transport Safety Council, 2003) and removal of roadside obstacles in Norway 
(European Transport Safety Council, 2003). There was an 80% reduction in 
casualty crashes at 13 blackspots in Australia, with net lifetime benefi ts of 
$22 million following the introduction of rumble strips, crash barriers and 
sealed shoulders (Meuleners, Hendrie & Lee, 2011). 
Speed enforcement programmes using automated speed monitoring devices, 
such as cameras and radar guns, generate net benefi ts in the short to medium 
term, especially if placed on road sections of known higher accident risk. 
Evidence from Canada (Chen, 2005), Spain (Mendivil et al., 2012) and 
the United Kingdom demonstrate net benefi ts: the latter programme, 
costing $179 million but generating benefi ts of $481 million by preventing 
4230 collisions resulting in personal injury (PA Consulting & UCL, 2005). 
Evidence from Norway and Sweden shows the potential of better prioritization 
of police enforcement of traffi c regulations and also generates positive net 
benefi ts that could reduce the number of fatalities without requiring any 
additional resources (Elvik et al., 2009, 2012; Elvik, 2010).
Seat belts are another effective measure in reducing the risk of mortality and 
serious injury, but there is only 70% usage in some western European contexts; 
their overall rate of effectiveness and cost–effectiveness can be improved 
through behaviour change to encourage routine use for all journeys (Cummins 
et al., 2008, 2011), including increased police enforcement, which has been 
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shown to have net benefi ts in different settings (Elvik, 2010; Conner, Xiang 
& Smith, 2010; Stevenson et al., 2008).
A number of studies suggest that special safety restraints for children in cars is 
effi cient. Estimates for Sweden show a benefi t–cost ratio of 3.23:1 for families 
buying seats (Elvik et al., 2009). One of the barriers to using car restraints is 
the high costs associated with the purchase. A model-based study looked 
at a scheme in a Greek hospital to allow new parents to borrow child seats 
through a low-cost loan scheme. Compared to no intervention, from a societal 
perspective the estimated incremental cost per life-year saved was $5550 
(Kedikoglou et al., 2005), while four-fi fths of families went on to purchase 
new child seats as their infants grew.
Mass media campaigns to reduce the rate of alcohol impaired driving have 
been shown to generate positive returns on investment due to accidents 
avoided in studies in the United States (Elder et al., 2004), Australia (Miller, 
Blewden & Zhang, 2004) and New Zealand (Miller, Blewden & Zhang, 2004). 
Raising the minimum legal drinking age from 18 to 21 has been modelled as 
being more cost-effective than random breath-tests or mass media campaigns 
in Australia, with both better outcomes and reduced costs (Cobiac et al., 
2009). There is increasing evidence that alcohol ignition interlocks can be 
cost-effective, as shown in mandatory use in commercial vehicles in Sweden 
(Magnusson, Jakobsson & Hultman, 2011) and all new cars in Australia 
(Lahausse & Fildes, 2009). 
Vehicle modifi cations, including ultraviolet headlights to increase visibility at 
night (Lestina et al., 2002) and daytime running lights (European Transport 
Safety Council, 2003), have shown positive economic impacts. Modest 
economic benefi ts have been estimated in studies looking at the use of airbags 
in cars (Graham et al., 1997) (Thompson, Segui-Gomez & Graham, 2002) 
(Williams et al., 2008b), but their cost–effectiveness is much lower than that 
of the use of seat belts or motorcycle helmets (Kent, Viano & Crandall, 2005). 
Models suggest that intelligent speed adaptation systems, if implemented, 
have the potential to be cost-effective (Lai, Carsten & Tate, 2012).
Some economic analysis has looked at licensing and driver education. For 
instance, imposing various restrictions on very late-night driving for those 
under 19 was estimated to have a benefi t–cost ratio of at least 4:1 (Miller, 
Lestina & Spicer, 1998); exposing learner drivers to additional supervised 
practice from lay drivers reported benefi ts outweighing costs by a factor of 30 
(Gregersen, Nyberg & Berg, 2003); and providing all older drivers with speed-
of-cognitive-processing interventions suggests that this is a less costly way of 
reducing the risk of collisions in older drivers compared to screening strategies 
(Viamonte, Ball & Kilgore, 2006). 
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There is inconsistent evidence from studies in New Zealand and the United 
States that national compulsory bicycle helmet laws would be cost-effective 
from a societal perspective. However, from a public sector perspective – 
critically, omitting the cost to individuals or families of purchasing bicycle 
helmets – the measure is likely to be highly cost-effective (Taylor & Scuffham, 
2002; Hansen & Scuffham, 1995; Hatziandreu et al., 1995). 
Motorcycle helmet legislation is already implemented in most European countries, 
although helmet wearing behaviour varies. Cost–benefi t analyses for mandatory 
motorcycle helmet laws in the United States have shown positive economic 
gains, for instance benefi t to cost ratios were 1.33:1 including helmet costs 
only (Rice, Mackenzie & Jones, 1989), 2.3:1 assuming a 100% compliance rate 
of wearing helmet (Muller, 1980), and 17:1 (Miller and Levy, 2000).
The development of any road safety strategy needs to be informed by evidence 
on both effectiveness and cost–effectiveness. As shown, there are reasonable 
clusters of good-quality economic evaluations for some interventions, 
sometimes in a range of different countries, but for some other aspects of 
road safety the pattern of economic evidence on preventing road injuries is 
dogged by a paucity of recent studies and extensive heterogeneity. Additionally, 
there is a scarcity of evaluative and economic evidence generated in low- and 
middle-income countries (Hyder & Aggarwal, 2009). This raises challenges in 
the potential transferability of cost-effective interventions across the European 
region. Another complication is that effective road safety policies will need to 
combine a range of actions at different levels – vehicle modifi cation, legislation, 
enforcement, media campaigns and road design. Therefore, there remains 
a need to further develop methods to estimate the effectiveness and cost–
effectiveness of different packages of road safety interventions that could be 
included in a national road safety policy.
8 Protecting mental health, preventing depression 
Poor mental health can have long-lasting impacts across the life course. 
Globally, major depressive disorders are the second leading cause of years 
lived with disability (Vos et al., 2012). They affect about 150 million people 
worldwide at any moment in time, including about 33.4 million people in 
the WHO European Region. The costs are substantial, with costs for major 
depression in 30 European countries estimated to be $113 billion in 2010, 
while costs for all anxiety disorders accounted for a further $91 billion (Olesen 
et al., 2012). All-cause mortality rates are higher by a factor of 1.65 in people 
with depression (de Hert et al., 2011). People with depression make more 
frequent use of health services and stay absent from their work more often, 
which has signifi cant economic ramifi cations; at least 60% of all suicides are 
in people who are depressed (Marquet et al., 2005). 
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Effective and cost-effective relatively simple and feasible actions that are 
potentially scalable to promote mental health and prevent the onset of mental 
health problems, across the life course and in different settings, are available 
(Smit et al., forthcoming). As Table 7 indicates, actions in childhood to both 
promote emotional health and well-being and address those behavioural 
problems that increase the risk of mental health problems in adulthood can be 
cost-effective (McDaid & Park, 2011; Mihalopoulos et al., 2012). For younger 
children at risk of developing conduct disorders, interventions targeting parents 
(Edwards et al., 2007), parents and children (Mihalopoulos et al., 2011) as well 
as those including parents, child-based training and teacher training (Foster, 
2010) can be cost-effective. Interventions to prevent depression in adolescents 
through after school screening and subsequent psychological intervention 
(Mihalopoulos et al., 2012) and targeting at-risk teenagers whose parents have 
depressive disorders (Lynch et al., 2005) would be considered cost-effective in 
most high-income country settings.
New mothers are another important target group for action. One in every 
seven new mothers is affected by post-partum depression (Wisner, Chambers 
& Sit, 2006), which may lead to increased risks of hospitalization, marital stress 
and divorce, child abuse and neglect, and maternal suicide and infanticide. 
Health visitor-led identifi cation of new mothers at risk of post-natal depression, 
coupled with subsequent therapy appears cost-effective (Bauer, Knapp & 
McDaid, 2011). 
For workplace interventions at an organizational level, potential economic 
benefi ts have been reported from investment in stress and well-being audits, 
better integration of occupational and primary health care systems, and an 
extension in fl exible working hours arrangements (Foresight Mental Capital and 
Wellbeing Project, 2008; Corbiere et al., 2009). There is also some workplace-
specifi c evidence on the economic benefi ts of mental health promoting actions 
targeted at individuals. Potentially, interventions that can prevent depression 
and anxiety can be cost-saving from a business perspective for white-collar 
employment (McDaid et al., 2011; Matrix Insight, 2012); however, additional 
evidence on different workplace settings, for example where staff turnover is 
high and skill requirements low, would help strengthen the case for companies 
to invest.
For older people, better mental health from regular participation in group-
based activities, such as exercise classes and psychosocial group therapy for 
those who are identifi ed as lonely have the potential to be cost-effective 
(McDaid & Park, 2011; Munro et al., 2004). A stepped care approach for the 
prevention of depression in older people, identifi ed as being at risk through 
primary care, has been shown to be more cost-effective than routine primary 
care in the Netherlands (Van’t Veer-Tazelaar et al., 2010). 
 Promoting health, preventing disease: is there an economic case?
21
Economic evidence also indicates that depression prevention in adults is 
potentially cost-effective (Zechmeister, Kilian & McDaid, 2008), especially 
when offered in a self-help format with minimal guidance from a therapist. 
It may even be cost-saving when cost offsets due to changes in productivity 
are accounted for (van den Berg et al., 2011). E-health delivered interventions 
do not rely on scarce resources such as therapists’ time, thus bringing down 
marginal costs signifi cantly (Warmerdam et al., 2010). They are scalable and 
potentially reach groups, such as young men, who may be unwilling to engage 
with face-to-face support.
Most of the evidence has been demonstrated in high-income country contexts; 
more is needed on cost-effective interventions in low- and middle-income 
countries, and on the long-term benefi ts of better psychological well-being. 
Nonetheless, the evidence indicates that the promotion of mental well-being 
to reduce the risk of becoming vulnerable to poor mental health, and strategies 
to protect the mental health of the population who are at risk of developing 
depression constitute a critical element of any mental health strategy. There is 
a case for careful investment in many actions, but these need to be sensitive to 
local conditions, culture, infrastructure and resources.
9 Investing in health promotion and disease prevention: 
there is an economic case
A large burden of disease, particularly from chronic non-communicable 
diseases, in the WHO European Region impacts heavily on labour markets and 
productivity. Diseases fuel disparities in employment opportunities and wages. 
They affect productivity at work, increase sick leave and the demand for welfare 
benefi ts. Poor health in childhood can have adverse consequences well into 
adulthood, limiting educational attainment and career opportunities, as well as 
affecting health. Health expenditure has grown at a pace exceeding economic 
growth in many European countries, resulting in increased fi nancial pressures 
which threaten the long-term sustainability of health care systems. Expensive 
medical treatments can generate important improvements in quality of life to 
populations, but they also drive up the cost of managing often multiple chronic 
diseases. It is therefore important to consider population-wide interventions 
that can help reduce the risks of poor health from occurring.
We have seen from the areas covered in this policy summary that there are 
strong economic, as well as health, reasons for investing in health promotion 
and disease prevention. Societies do not perfectly allocate information on 
which the population can best make decisions about they way in which they 
maintain their health. Individuals can also be myopic about the benefi ts of 
healthy lifestyles in protecting their health; choosing instead to “enjoy” the 
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benefi ts of an unhealthy lifestyle today, intending at some future point in time 
to change their health behaviour, but often never succeeding in doing this. 
They may also have unrealistic views of their own risks of poor health, failing 
to comprehend their much increased chances of having poor health in later 
life. Moreover, there are externalities associated with the adverse impacts of 
avoidable poor health that go beyond the individual; they affect families and 
can put a strain on public services. 
Income and educational inequalities have an impact on an individual’s stock 
of healthy human capital; health-related choices will also be constrained by 
income. Individuals do not choose where they are born, the socioeconomic 
environment in which we all live also has an impact on our lives; this can, for 
instance, limit our access to activities to promote or protect our physical health. 
Higher levels of environmental pollution in urban conurbations, for instance 
from car exhaust emissions or contaminated water supplies, can have profound 
long-term consequences for city dwellers, especially children. There may also be 
greater risks of injury and death in road environments as a result of the process 
of creeping urbanization and economic development bringing more and more 
suburban areas into contact with major road systems.
We have also seen major changes in the world of work away from manual to 
service sector oriented activities. There has been a blurring of the distinction 
between our private lives and work, coupled with constant short work 
deadlines and much less job security. All of these factors have been associated 
with greater risks of developing poor mental health, with depression and 
anxiety projected to be the leading contributor to the global burden of disease 
by 2030. 
Thus a strong economic case for action to promote health and prevent disease 
can be made. Effective measures both within and beyond the health system are 
available. The rationale for government action to promote healthy behaviours 
is particularly strong given the presence of negative externalities from 
unhealthy behaviours and the inadequacy of information. As we have seen 
in this summary, a growing body of evidence from economic studies shows 
areas where appropriate policies can generate health and other benefi ts at an 
affordable cost, sometimes reducing health expenditure and helping to redress 
health inequalities at the same time. For instance, the victims of second-hand 
smoke and drunk drivers provide dramatic examples of negative additional 
consequences or externalities that can be corrected either by excise taxes 
on tobacco and alcohol, or other policies such as public smoking bans and 
drink-driving laws. Inadequate consumer information justifi es interventions to 
promote healthier behaviours by informing people about the risks of smoking, 
obesity and other causes of disease, and providing them with more information 
on the food and drink that they consume. These externalities also provide a 
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justifi cation for the use of fi scal measures to infl uence the price of food and 
drink and change overall patterns of consumption.
9.1 Is the evidence base strong enough?
The areas for action examined in this policy summary have deliberately moved 
beyond what is known about the economic benefi ts of specifi c actions within 
health care systems, such as vaccinations and screening, to look at research 
endeavours to make the economic case for investing upstream – that is prior 
to the onset of non-communicable diseases, and before health care services 
are required. The work highlights actions that can supported by sound cost–
effectiveness or cost–benefi t analyses, including actions to limit risky behaviours 
such as tobacco use and alcohol consumption, to promote physical and 
mental health through diet, exercise and prevention of mental disorders, and 
to decrease preventable injuries, for example from road traffi c accidents and 
exposure to environmental hazards. We have also looked separately at the 
evidence base for investment in early childhood development and the benefi ts 
to health that may be seen from education.
The majority of studies that we have identifi ed rely on different types of 
modelling analyses in order to synthesize evidence on effectiveness and costs. 
In particular, models have been used to estimate some of the very long-term 
benefi ts of better health that are not usually possible to monitor in controlled 
trials and other observational studies. There are limitations in models and 
caution must be used in their interpretation, although some of these limitations 
can be address by adjusting the values and assumptions in models to see what 
difference this makes to fi ndings. Where economic data are linked to actual 
implemented health promoting actions, there are still limitations to be mindful of, 
as the effectiveness of any intervention may differ depending on local context.
Notwithstanding these limitations, it is clear that there is strong evidence 
of cost-effective actions in many of these areas, for example for tobacco 
control programmes, many of which are inexpensive to implement and have 
cost-saving effects. Such programmes include raising taxes in a coordinated 
way with high minimum tax (which is the single most cost-effective action), 
encouraging smoke-free environments, banning advertising and promotion, 
and deploying media campaigns. Adequate implementation and monitoring, 
government policies independent of the tobacco industry, and action against 
corruption are needed to support effective policies.
The cost–effectiveness of alcohol policies is supported by a substantive 
evidence base of systematic reviews and meta-analyses. Very cost-effective 
interventions include: restricting access to retailed alcohol; enforcing bans 
on alcohol advertising, including in social media; raising taxes on alcohol 
and instituting a minimum price per gram of alcohol. Less, but still somewhat 
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cost-effective measures include: enforcing drink-driving laws through breath-
testing; delivering brief advice for higher-risk drinking and providing treatment 
for alcohol-related disorders. Media campaigns on their own and school-based 
health promotion programmes do not appear to be cost-effective.
Actions to promote healthy eating are especially cost-effective when carried 
out at the population rather than health care service level. Reformulation of 
processed food to decrease salt and saturated fat (trans fat, in particular) is 
a low-cost intervention which may be pursued through multi-stakeholder 
agreements. Fiscal measures (including taxes and subsidies) and regulation 
of food advertising to children also have a low cost and a favourable cost–
effectiveness. However, feasibility could be hindered by confl icting interests. 
Programmes to increase awareness and information, such as mass media 
campaigns and food labelling schemes, are also effi cient investments but 
with poorer effectiveness, particularly in lower socioeconomic groups.
The promotion of physical activity through mass media campaigns is a very 
cost-effective action, and relatively inexpensive. However, returns in terms 
of health outcomes may be lower than those provided by more targeted 
interventions, for instance, those set in the workplace. Changes in the 
transport system and increased access to opportunities for physical activity 
in the wider environment, such as the provision of bicycle trails, also have 
potential economic benefi ts, but require careful evaluation to ascertain 
affordability and feasibility. Actions targeting the adult population and 
individuals at higher risk tend to produce larger effects in a shorter time-
frame compared with actions targeted at children and young people.
Robust evidence indicates that the prevention of depression, the single leading 
cause of disability worldwide, is feasible and cost-effective. Depression is 
associated with premature death and reduced family functioning, and it 
entails staggering economic costs due to health care and productivity losses, 
which can be partly avoided through appropriate forms of prevention and 
early detection. Evidence supports actions across the life course, starting from 
early actions in childhood to strengthen social and emotional learning, coping 
skills and improved bonds between parents and children, which can generate 
benefi ts lasting into adulthood. There are also cost-effective programmes 
targeted at high-risk groups such as isolated older people and new mothers.
Actions to prevent road traffi c accidents, such as those through road design 
modifi cation, urban traffi c calming (e.g. mandatory speed limits with physical 
measures), and camera and radar speed enforcement programmes, are 
supported by sound economic evidence, especially when applied in higher-
risk areas. Active enforcement of legislation to promote good road safety 
behaviours, including measures to reduce drink-driving, can also be highly 
cost-effective.
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Evidence from economic studies supports actions to tackle environmental 
chemical hazards. Examples include comprehensive chemical regulatory reform 
such as that implemented in 2007 under the REACH in Europe; the removal of 
lead-based paint hazards; the abatement of mercury pollution from coal-fi red 
power plants; and the abatement of vehicle emissions in high-traffi c areas, 
for example, through congestion charging schemes used in many metropolitan 
areas, which may produce savings in health care and other costs associated 
with childhood asthma, bronchiolitis and other early life respiratory illnesses.
In addition to the thematic areas discussed earlier it is also important to look at 
other factors that infl uence our health and well-being. Investments in education 
are also investments in health: a growing body of empirical research suggests 
that when countries adopt policies to increase education, the investments also 
pay off in healthier behaviours and longer and healthier lives. For example, studies 
of compulsory schooling reforms adopted in a number of European countries 
conclude that the reforms not only lead to additional years of completed 
schooling, but also that this additional schooling reduces population rates of 
smoking and obesity (McDaid, Sassi & Merkur, forthcoming). When countries 
consider the return on investment in education and other social determinants 
of health, the analysis should also factor in the potential health gains.
9.2 What does this evidence tell us about impacts on inequalities?
Much of the evidence base we have discussed in this policy summary does not 
explicitly consider the impacts of health promoting actions on inequalities in 
health status and/or use of health care services. Yet central to most, if not all, 
health promotion and disease prevention programmes is the aim of reducing 
health inequality. Some prevention programmes, once implemented, do not rely 
on individuals to engage with the programme for a long period of time in order 
to reap the benefi ts. For instance, a one-off decision to be screened or to give 
up smoking for a short period of time (e.g. during pregnancy) is likely to be 
more effective than those that require sustained behaviour change.
Many prevention programmes require regular levels of participation in a 
health promoting activity. There is therefore a danger that investment in health 
promotion could widen health inequalities if these disadvantaged groups do 
not participate. Across the general population, access and take-up tends to be 
lowest in more disadvantaged groups. 
Actions may need to be tailored so they are attractive to many social groups; 
cultural and religious sensitivities can also be accounted for. This might involve 
targeting disadvantaged individuals to improve their health relative to more 
advantaged individuals, or delivering programmes to all to raise the health 
of all, including those who are most disadvantaged. Investing in community 
engagement measures, including peer delivered programmes, to increase the 
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uptake of disease prevention and health promoting interventions can also be 
cost-effective (O’Mara-Eves et al., 2013).
Policy-makers should therefore be cautious in designing and implementing 
prevention programmes to ensure that they do not increase health inequalities 
or discriminate among groups of the population by demographic (e.g. age, 
gender, ethnicity) and/or socioeconomic variables (e.g. income, education). 
There is still relatively little evaluation to assess the effectiveness of prevention 
programmes and the impact of these programmes on health inequality 
(O’Mara-Eves et al., 2013). As improvement in health inequalities is of such 
importance within the public health arena, continuous, ongoing evaluation of 
health promotion and disease prevention programmes is required to monitor 
them and mitigate any unintended consequences, including through the 
possible re-design of programmes.
9.3 How can we facilitate implementation and promote uptake?
Of course, it is insuffi cient either simply to identify that there is an economic 
case for action or even to identify cost-effective interventions. It is important 
to consider the challenges of implementation and ways in which to promote 
the uptake and continued use of health promoting interventions when they 
are in place. We look at each of these issues in turn and at how knowledge 
on cost-effective actions may be translated into actions that help improve 
population health.
One challenge concerns the different economic incentives that are faced by 
different stakeholders. Ministries of health that wish to promote health by 
tackling the social determinants of health (SDH) face a fundamental diffi culty: 
other ministries jointly and indirectly shape these determinants with their policies 
and programmes, through often tangential or unrelated objectives. Indeed, 
lifestyles; social and community networks; living and working conditions; and 
general socioeconomic, cultural and environmental conditions are all multifaceted 
determinants of health which cannot easily be tackled by direct ministry action 
or be attributed to a single policy or sectoral activity outside of health.
For instance, take the area of alcohol control. This will require actions in 
respect of taxation, retail, transport, education, economic development, 
criminal justice and social welfare. These will be the responsibility of different 
stakeholders, who will have different policy goals, such as stimulating economic 
activity, which may or may not be conducive to health. Implementing health 
promoting actions within different departmental fi efdoms and budgetary 
silos can therefore be challenging. Education budget holders, for instance, 
are more likely to be concerned with how their funds might affect average 
examination grade scores on national tests or the level of truancy in schools, 
rather than the social and emotional well-being of children. That is not to say 
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that health concerns are completely off the radar: for instance, ministries of 
transport usually have dedicated budgets and plans to promote safety on the 
road. Nonetheless, if the predominance of vertical policy structures and funding 
silos remains unchallenged, many health concerns that potentially could be 
addressed through actions outside the health care system remain of low 
concern to these policy-makers 
Take, for instance, action to improve the health and well-being of children at 
school, one of the few places where public health interventions can easily reach 
most children. We have noted that there is an evidence base for early childhood 
development and school-based measures including parenting programmes. 
However, the education sector may be reluctant to invest its limited resources 
in school-based mental health promotion programmes rather than core 
education-related activities. This reluctance may be even more pronounced 
in times of constrained economic circumstances, when all public services are 
under heightened pressure to demonstrate their effi ciency and added value. 
One way round this issue may be to identify benefi ts of direct interest to 
the sector in question in addition to health sector benefi ts; some studies 
of social and emotional well-being actions for children have demonstrated 
that they reduce the need for special education classes and make classroom 
disruption rarer; in Canada one such programme has been shown to reduce 
the risk that children have to repeat a whole school year (Peters, Bradshaw 
& Petrunka, 2010). Similar approaches have been used when looking at the 
economic benefi ts of investing in workplace health promotion programmes, 
where benefi ts to business in terms of better performance by workers when 
at work, and greater levels of employee retention and creativity have been 
cited, alongside some of the benefi ts of reduced levels of time off work due 
to depression and anxiety problems (Matrix Insight, 2012). 
Another way in which to encourage implementation of health promoting 
activities across sectors is to engage at a very early stage in the evidence-
informed policy-making process with these stakeholders. This has been the 
case for public health evaluation for England undertaken by NICE. Since 2005 
NICE has assessed the effectiveness and cost–effectiveness of a very broad 
range of public health interventions, all of which are implemented within 
public health programmes or in other sectors, such as schools, workplaces, 
on the roads and in people’s homes. This process does not simply involve 
synthesizing evidence and constructing cost–effectiveness models. It involves 
much stakeholder consultation, including the co-opting of different topic-
specifi c experts onto committees assessing the evidence. Unlike assessment 
of health care technologies at NICE, a broader perspective on costs is often 
presented, looking at the impacts outside the health sector. This can be helpful 
in encouraging the adoption of guidance: for instance, in one of its fi rst pieces 
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of guidance on public health interventions, arguments on reduced time out of 
the workplace if a ban on smoking at work could be initiated were helpful in 
getting employers on side.
Another way in which cross-sectoral actions may be facilitated is to look at 
ways of changing funding arrangements to overcome narrow sector-specifi c 
interests. For example, cross-sectoral collaboration could be fostered through 
establishing one single budget for the provision of school-based health 
promotion (McDaid, 2012). Creating a dedicated budget for a non-health 
sector health promoting activity, bringing together resources from the health 
sector and beyond, provides health policy-makers with a direct means of 
infl uencing policy in other sectors. For instance, the approach might be used 
to ensure adequate funding and priority is given to road safety measures by 
ministries of transport, or to address health concerns in new urban housing 
developments. Such a pooling of budgets might be done on a mandatory 
or voluntary basis. Approaches whereby different sectors come together 
voluntarily to pool funds will take more time to establish. They rely more heavily 
on securing the buy-in of different stakeholders by demonstrating the potential 
added value of collaboration, both in terms of health and regarding objectives 
of importance to other sectors. They also rely more heavily on trust and 
open discussion; in turn, mutual learning and innovation is enhanced by the 
development of trusting relationships. Voluntary pooling of resources may thus 
be more sustainable in the long term as long as all partners have a sense of 
ownership over collaboration, making them more willing to continue to make 
a contribution towards the pooled budget.
10 Conclusions
Reducing the risk of chronic diseases and injury through interventions aimed 
at modifying lifestyle risk factors is possible and cost-effective, and potentially 
could reduce health inequalities within countries. However, turning the tide of 
chronic health problems that have assumed epidemic proportions during the 
course of the twentieth century requires fundamental changes in the social 
norms that regulate individual and collective behaviours. Such changes can 
only be triggered by wide-ranging prevention strategies addressing multiple 
determinants of health across social groups.
Most countries are putting efforts into improving health education and 
information. The evidence in this summary suggests, however, that these 
measures alone are not suffi cient, nor are they always cost-effective. More 
stringent measures, such as regulation of advertising or fi scal measures, are 
more intrusive on individual choices and more likely to generate confl ict among 
relevant stakeholders, but are also likely to weigh less on public fi nances and to 
produce health returns more promptly.
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A wide range of regulatory and fi scal measures have been put in place in 
many countries, for instance to curb consumption of tobacco and alcohol. 
A minimum age has been set for purchasing cigarettes and alcoholic drinks, 
which often carry health warnings printed on their labels. Advertising has been 
severely restricted and hefty taxes have been imposed on the consumption 
of both commodities. All of these measures have contributed to containing 
consumption and modelling studies have shown that most have very favourable 
cost–effectiveness profi les. However, fi scal measures are complex to design and 
enforce; their impact may be unpredictable; and they can bear more heavily on 
low-income groups than on those with higher incomes.
The complex nature of chronic diseases, their multiple determinants and causal 
pathways suggest that pervasive and sustained efforts and comprehensive 
strategies involving a variety of actions and actors are required for successful 
prevention. Governments still spend only a fraction of their health budgets 
on prevention (on average around 3% of total health expenditure, in OECD 
countries), although some activities will be funded from other budgets. In any 
case, providing economic incentives or changing fi nancing arrangements within 
countries to foster cross-sectoral activity may help to increase the overall level 
of resources invested in health promotion and disease prevention.
It is also crucial that expectations concerning the benefi ts of health promotion 
and disease prevention remain realistic. Prevention can improve health and 
well-being, with a cost–effectiveness that is as good as, or better than, that 
of many accepted forms of health care. However, reducing health expenditure 
should not be regarded as the sole goal of prevention, because many 
programmes will not have this effect. In saying this, low-cost population-wide 
strategies can have substantial capacity to generate economic returns if they 
only improve the health of a very small fraction of the population. 
It is also important to recognize the differing contexts in which health 
promotion and disease prevention programmes are implemented; they 
require adaptation to different infrastructures and cultures and we are 
mindful of the concentration of evidence on what works within North America, 
Australasia and western Europe. This issue of equity is a particularly important 
consideration. If the uptake of a public health intervention is higher in more 
affl uent groups in society then one unintended consequence of investment in 
a public health programme could be to inadvertently widen health inequalities.
Notwithstanding these caveats, it is clear that there is an economics evidence 
base for health promotion and disease prevention. The challenge now is to 
strengthen this evidence base further and look at ways in which it may be used 
to translate evidence-based knowledge into routine everyday practice across all 
of the WHO European Region.
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Health promotion and disease prevention programmes – 
Summary tables of economic evidence 
The subsequent tables provide summaries of the existing evidence of the 
economic impact of a range of health promotion and disease prevention 
programmes, discussed in the policy summary document. The tables, organized 
by risk factor area, are not meant to provide an exhaustive account of all 
economic studies undertaken in each area. Rather, they are designed to provide 
an interpretation and brief assessment of evidence related to relevant chapters 
of the book “Promoting health, preventing disease: the economic case” 
(McDaid, Sassi & Merkur, forthcoming).
As readers who are familiar with the economic evidence base for public health 
action will know all too well, the available evidence is extremely heterogeneous. 
The programmes assessed are very diverse, as are the evaluation approaches 
applied, the countries where studies were undertaken, the outcome measures, 
the time-frames, the perspectives adopted in the studies, and, not least, the 
generalizability of the fi ndings. Moreover, fi ndings are often nuanced, and 
may vary in the same study depending on the way programmes are designed 
or implemented. The imperative of synthesizing their direction in a table 
cell may not do justice to the authors’ efforts to ascertain what factors 
may be associated with better or worse economic outcomes. In this context, 
summarizing the evidence base in concise tables is a challenge, and no doubt 
the tables included in this section, as well as the whole body of evidence 
discussed in this document, are only a starting point for policy-makers wishing 
to use the existing evidence base in support of their policy decisions. Assessing 
whether the fi ndings of individual studies are relevant in a specifi c policy setting 
requires a detailed analysis of the design, assumptions, data and inferences 
made in those studies. What the tables do provide, however, is a broad-brush 
overview of areas and programmes that are more, or less, strongly supported 
by existing evidence, offering initial guidance to decision-makers towards an 
evidence-based approach to public health policy.
The tables contain the following elements:
1. Programme description. Short description of the intervention(s) assessed 
in the referenced studies. Descriptions may contain details that help to 
distinguish the intervention from similar ones listed in the same section 
of the table.
2. Economic impact. Summary assessment of the economic studies’ 
conclusions. It is important to note that studies may have been undertaken 
using different approaches. The assessment is on three levels, as follows:
(i) Cost saving. A lower cost and better health outcomes than a situation 
in which the programme were not available.
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(ii) Effi cient. A favourable cost–effectiveness ratio (lower than accepted 
thresholds in the relevant countries); a positive net present value, 
a cost–benefi t ratio greater than 1, or a favourable internal rate of 
return (for cost-benefi t analyses). Good value for the money invested.
(iii) Borderline. Close to the relevant cost–effectiveness or cost–benefi t 
thresholds.
(iv) Ineffi cient. High costs relative to the health outcomes generated by the 
programme. Poor value for the money invested.
3. Strength of economic evidence. Summary assessment based on the size 
and consistency of the evidence base for the specifi c programme. The 
assessment is on fi ve levels, as follows:
(i) Single study. Only one study is available on the specifi c programme.
(ii) Two or three studies with inconsistent fi ndings. Two or three studies 
are available, but their conclusions do not consistently point to the 
programme being effi cient or ineffi cient. More information may be 
provided in the “Comments” column.
(iii) Two or three studies with consistent fi ndings. Two or three studies are 
available whose conclusions consistently point in the direction indicated 
in the “Economic impact” column.
(iv) Multiple studies with inconsistent fi ndings. More than three studies 
are available, but their conclusions do not consistently point to the 
programme being effi cient or ineffi cient. More information may be 
provided in the “Comments” column.
(v) Multiple studies with consistent fi ndings. More than three studies are 
available, whose conclusions consistently point in the direction indicated 
in the “Economic impact” column.
4. Cross-national assessment. Two-part assessment refl ecting the country 
coverage of studies available on a specifi c programme, including breadth 
of coverage and levels of income of the countries concerned. Breadth 
of coverage is assessed in three levels, as follows:
(i) Single country. Evidence from studies based in, or covering, only one country.
(ii) Few countries. Evidence from studies based in, or covering, no more than 
three countries. More information may be provided in the “Comments” 
column.
(iii) Multiple countries. Evidence from studies based in, or covering, a larger 
number of countries.
5. Comments. This section has relevant additional information about the evidence 
available on a specifi c programme. This may include details of study design, an 
assessment of the overall quality of the studies, and other relevant information. 
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at
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, c
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 m
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d
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l c
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 c
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 p
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 m
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 c
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 c
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b
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 p
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 c
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 c
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 c
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 c
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 c
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 m
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 c
o
st
s.
 Policy summary
56
St
u
d
ie
s
D
es
cr
ip
ti
o
n
Ec
o
n
o
m
ic
 
im
p
ac
t
St
re
n
g
th
 o
f 
ec
o
n
o
m
ic
 
ev
id
en
ce
C
ro
ss
-n
at
io
n
al
 
ap
p
lic
at
io
n
C
o
m
m
en
ts
Pu
b
lic
 a
w
ar
en
es
s 
ca
m
p
ai
g
n
s 
(c
o
n
ti
n
u
ed
)
(W
o
o
ta
n
 e
t 
al
., 
20
05
)
6–
8 
w
ee
k 
in
te
n
si
ve
 
p
o
p
u
la
ti
o
n
-w
id
e 
in
fo
rm
at
io
n
 c
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d
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 p
o
p
u
la
ti
o
n
 t
o
 s
w
it
ch
 t
o
 1
%
 
o
r 
le
ss
 f
at
 m
ilk
; f
o
u
r 
lo
ca
ti
o
n
s;
 f
o
u
r 
d
if
fe
re
n
t 
ca
m
p
ai
g
n
s;
 p
ro
fe
ss
io
n
al
 
ad
ve
rt
is
in
g
 a
n
d
 m
ed
ia
 e
ve
n
ts
 lo
w
es
t 
co
st
 p
er
 in
d
iv
id
u
al
 a
t 
$0
.5
7 
to
 
$1
1.
85
 f
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p
lu
s 
m
ed
ia
 e
ve
n
ts
. U
n
cl
ea
r 
w
h
et
h
er
 t
h
is
 
w
ill
 u
lt
im
at
el
y 
b
e 
co
st
-e
ff
ec
ti
ve
. 
La
b
el
lin
g
 
(C
o
b
ia
c,
 V
o
s 
&
 
V
ee
rm
an
, 2
01
0a
)
V
o
lu
n
ta
ry
 o
r 
m
an
d
at
o
ry
 
u
se
 o
f 
a 
“t
ic
k”
 t
o
 in
d
ic
at
e 
lo
w
 s
al
t 
co
n
te
n
t 
b
re
ad
, 
m
ar
g
ar
in
e 
o
r 
ce
re
al
C
o
st
-s
av
in
g
Si
n
g
le
 s
tu
d
y
O
n
e 
h
ig
h
-i
n
co
m
e 
co
u
n
tr
y
Si
m
u
la
ti
o
n
 m
o
d
el
lin
g
 u
se
d
 t
o
 a
d
ap
t 
ef
fe
ct
iv
en
es
s 
ev
id
en
ce
 t
o
 A
u
st
ra
lia
n
 
co
n
te
xt
 a
n
d
 s
yn
th
es
is
 w
it
h
 c
o
st
s.
(S
as
si
 e
t 
al
., 
20
09
)
N
u
tr
ie
n
t 
la
b
el
lin
g
Ef
fi 
ci
en
t
Si
n
g
le
 s
tu
d
y
M
u
lt
ip
le
 c
o
u
n
tr
ie
s 
w
it
h
 d
if
fe
re
n
t 
le
ve
ls
 o
f 
in
co
m
e 
Si
m
u
la
ti
o
n
 m
o
d
el
lin
g
 s
yn
th
es
iz
in
g
 
d
at
a 
o
n
 e
ff
ec
ti
ve
n
es
s 
an
d
 c
o
st
s.
 
Ef
fi 
ci
en
t 
af
te
r 
10
 y
ea
rs
.
La
b
el
lin
g
 a
n
d
 p
u
b
lic
 a
w
ar
en
es
s 
ca
m
p
ai
g
n
(S
ac
ks
 e
t 
al
., 
20
11
)
Fr
o
n
t-
o
f-
p
ac
k 
“t
ra
ffi
 c
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at
io
n
. E
q
u
iv
o
ca
l 
ev
id
en
ce
 f
ro
m
 o
th
er
 s
tu
d
ie
s 
o
n
 e
ff
ec
ti
ve
n
es
s 
o
f 
la
b
el
lin
g
.
Ta
b
le
 3
: U
n
h
ea
lt
h
y 
d
ie
ts
 (
co
n
ti
n
u
ed
)
 Promoting health, preventing disease: is there an economic case?
57
St
u
d
ie
s
D
es
cr
ip
ti
o
n
Ec
o
n
o
m
ic
 
im
p
ac
t
St
re
n
g
th
 o
f 
ec
o
n
o
m
ic
 
ev
id
en
ce
C
ro
ss
-n
at
io
n
al
 
ap
p
lic
at
io
n
C
o
m
m
en
ts
A
d
ve
rt
is
in
g
 r
eg
u
la
ti
o
n
(C
ec
ch
in
i e
t 
al
., 
20
10
)
Fo
o
d
 a
d
ve
rt
is
in
g
 r
eg
u
la
ti
o
n
 
to
 c
h
ild
re
n
Ef
fi 
ci
en
t
Si
n
g
le
 s
tu
d
y
M
u
lt
ip
le
 c
o
u
n
tr
ie
s 
w
it
h
 d
if
fe
re
n
t 
le
ve
ls
 o
f 
in
co
m
e
Si
m
u
la
ti
o
n
 m
o
d
el
lin
g
 s
yn
th
es
iz
in
g
 
d
at
a 
o
n
 e
ff
ec
ti
ve
n
es
s,
 e
p
id
em
io
lo
g
y 
an
d
 c
o
st
s.
 In
 s
ix
 o
f 
se
ve
n
 c
o
u
n
tr
ie
s 
ef
fi 
ci
en
t 
o
r 
co
st
-s
av
in
g
 in
 2
0 
ye
ar
s;
 
ef
fi 
ci
en
t 
in
 a
ll 
in
 5
0 
ye
ar
s.
 
(S
as
si
 e
t 
al
., 
20
09
)
M
an
d
at
o
ry
 a
n
d
 v
o
lu
n
ta
ry
 
in
d
u
st
ry
 r
eg
u
la
ti
o
n
 f
o
r 
fo
o
d
 a
d
ve
rt
is
in
g
 
to
 c
h
ild
re
n
 
Ef
fi 
ci
en
t
Si
n
g
le
 s
tu
d
y
M
u
lt
ip
le
 c
o
u
n
tr
ie
s 
w
it
h
 d
if
fe
re
n
t 
le
ve
ls
 o
f 
in
co
m
e
Si
m
u
la
ti
o
n
 m
o
d
el
lin
g
 s
yn
th
es
iz
in
g
 
d
at
a 
o
n
 e
ff
ec
ti
ve
n
es
s 
an
d
 c
o
st
s.
 
B
ec
o
m
es
 e
ffi
 c
ie
n
t 
af
te
r 
20
 y
ea
rs
; 
se
lf
-r
eg
u
la
ti
o
n
 c
an
 b
e 
co
st
-s
av
in
g
.
(S
as
si
, 2
01
0)
M
an
d
at
o
ry
 a
n
d
 v
o
lu
n
ta
ry
 
in
d
u
st
ry
 r
eg
u
la
ti
o
n
 f
o
r 
fo
o
d
 a
d
ve
rt
is
in
g
 
to
 c
h
ild
re
n
 
Ef
fi 
ci
en
t
Si
n
g
le
 s
tu
d
y
M
u
lt
ip
le
 
co
u
n
tr
ie
s;
 
p
re
d
o
m
in
an
tl
y 
h
ig
h
-i
n
co
m
e
Si
m
u
la
ti
o
n
 m
o
d
el
lin
g
 s
yn
th
es
iz
in
g
 
d
at
a 
o
n
 e
ff
ec
ti
ve
n
es
s 
an
d
 c
o
st
s.
 
B
ec
o
m
es
 e
ffi
 c
ie
n
t 
af
te
r 
20
 y
ea
rs
; 
se
lf
-r
eg
u
la
ti
o
n
 c
an
 b
e 
co
st
-s
av
in
g
.
(M
ag
n
u
s 
et
 a
l.,
 2
00
9)
B
an
n
in
g
 T
V
 a
d
ve
rt
s 
fo
r 
en
er
g
y-
d
en
se
 n
u
tr
ie
n
t-
p
o
o
r 
fo
o
d
 a
n
d
 d
ri
n
k 
d
u
ri
n
g
 
ch
ild
re
n
’s
 p
ea
k 
vi
ew
in
g
 
ti
m
es
C
o
st
-s
av
in
g
Si
n
g
le
 s
tu
d
y
O
n
e 
h
ig
h
-i
n
co
m
e 
co
u
n
tr
y
Si
m
u
la
ti
o
n
 m
o
d
el
lin
g
 u
se
d
 t
o
 a
d
ap
t 
ef
fe
ct
iv
en
es
s 
ev
id
en
ce
 t
o
 A
u
st
ra
lia
n
 
co
n
te
xt
 a
n
d
 s
yn
th
es
is
 w
it
h
 c
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d
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 b
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 f
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 p
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b
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 f
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 c
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 f
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 b
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 b
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 b
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d
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 d
at
a 
o
n
 
ef
fe
ct
iv
en
es
s,
 im
p
ac
t 
o
f 
le
ad
 e
xp
o
su
re
 
an
d
 c
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b
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 c
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 b
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 b
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b
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 c
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 d
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p
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